GILEAD SCIENCES, INC. Available-for-sale Securities
GILEAD SCIENCES, INC. (GILD) had Available-for-sale Securities of $34.94 billion as of 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecurities · last filed 2018-02-27
- 2017-12-31: Available-for-sale Securities $34.94B.
- 2017-09-30: Available-for-sale Securities $40.05B.
- 2017-06-30: Available-for-sale Securities $35.25B.
- 2017-03-31: Available-for-sale Securities $32.39B.
| Period end | Available-for-sale Securities | Available-for-sale Securities as first filed |
|---|---|---|
| 2017-12-31 | $34.94B 10-K · filed 2018-02-27 | |
| 2017-09-30 | $40.05B 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $35.25B 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $32.39B 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $30.29B 10-K · filed 2018-02-27 | |
| 2016-09-30 | $29.63B 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $22.99B 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $17.46B 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $23.52B 10-K · filed 2017-02-27 | |
| 2015-09-30 | $23.22B 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $12.89B 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $11.77B 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $9.63B 10-Q · filed 2015-11-04 | |
| 2013-12-31 | $1.95B 10-K · filed 2015-02-25 | |
| 2013-09-30 | $2.31B 10-Q · filed 2013-10-31 | |
| 2013-06-30 | $2.64B 10-Q · filed 2013-08-01 | |
| 2012-12-31 | $2.19B 10-Q · filed 2013-10-31 | |
| 2011-03-31 | $6.34B 10-Q · filed 2011-05-09 | |
| 2010-12-31 | $4.95B 10-Q · filed 2011-05-09 | $4.43B 10-K · filed 2011-02-28 |
| 2010-09-30 | $4.26B 10-Q · filed 2010-11-08 | |
| 2010-06-30 | $2.78B 10-Q · filed 2010-08-09 | |
| 2009-12-31 | $2.68B 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |